Connect Sign In
The COVID-19 pandemic has forced laboratories to adapt to an ever-shifting landscape that has challenged many foundational practices for laboratory management.
Perhaps more than ever before, ARUP Blood Services is relying on high school students to help save lives through blood donations, as its usual donor sources have diminished.
A new structure is slowly rising to distinguish the core of University of Utah Research Park. By mid-2021, the building will be the state-of-the-art epicenter of ARUP’s growing operations.
ARUP Laboratories now offers testing to detect the virus that causes COVID-19 using saliva specimens. The molecular diagnostic test is available with preapproval to ARUP clients nationwide.
As a national EAP program to deliver COVID-19 convalescent plasma to hospitalized patients with COVID-19 concludes, researchers are transitioning to multicenter randomized clinical trials.
Telemedicine has become a necessity during the COVID-19 pandemic, and hospital laboratories need to be prepared to modify their operations to accommodate this new mode of delivering healthcare.
The American Society for Clinical Pathology (ASCP) has recognized two ARUP Laboratories employees through its annual 40 Under Forty Program.
When supplies of a critical component of kits used to collect specimens for COVID-19 testing suddenly grew scarce, scientists at ARUP worked to formulate an alternative.
Self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19, according to a new study.
While many companies are laying off or furloughing employees due to the COVID-19 pandemic, ARUP is experiencing a hiring surge as the company continues to expand its COVID-19 testing capacity.
When one of the University of Utah’s (U of U’s) AirMed helicopters take off on an emergency call, there is now a small cooler onboard containing their latest means of saving lives — blood.
Karl Voelkerding, MD, FCAP, retired from his position as medical director of genomics and bioinformatics at ARUP on July 1, 2020. Karl Voelkerding, MD, FCAP, once imagined practicing medicine as a primary care physician in a rural setting. Instead, Voelkerding would become one the world’s leading experts in NGS.
